Ann: VIRALEZE Protects Against SARS-CoV-2 in Challenge Model, page-33

So, I sent out some emails last week after the latest clinical data from the challenge model, attaching the article from the "Viruses" journal and company release. Some of my emails were following up on previous correspondence with the likes of Which? and MHRA, which I posted on HC at the time.

The tone has shifted in the latest responses with the new information supplied, which seems to have piqued some interest rather than just the standard dismissive replies. I also got a response from Brett Sutton's EA.

I figure the more this gets out there and the more pressure is brought to bear in the right places, the more chance there is of getting Viraleze back on the shelves, including here. I hope SPL is running with this, because latest data they released could be a game-changer.



From Which?

Dear Mr >>>>,

Thank you for your email. I've shared your findings with the research team and they thank you for sharing this with us. They have advised that they may include the information in future news stories that we might cover on this subject in the near future.

If there is anything further I can assist you with, please do not hesitate to reply to this email.

Kind regards,

C>>>>>
Complaints Handler


Which? Complaints Team
E: [email protected]| which.co.uk
Which?, 3 Capital Quarter, Tyndall Street, Cardiff, CF10 4BT

At Which? (comprising the Consumers’ Association, Which? Limited and Which? Financial Services Limited) we're committed to protecting your personal information.




From MHRA:

Our Reference: CSC 646>>>

Dear J>>>>>,

Thank you for your email and for providing this information to us.

We have reviewed your enquiry and this has been passed on for consideration.

I hope you and your family are staying well.

Should you have any other questions or requests please feel free to call us on 0203 080 6000 or email at [email protected]

Our opening hours are Mon – Fri 9am to 5pm (excluding UK Public Holidays)

Kind Regards

E>>>>
MHRA Customer Service Centre
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU Telephone 020 3080 6000

gov.uk/mhra Stay connected
For information on how the Agency uses your personal data and your data protection rights, please see our three centres’ Privacy Notices: MHRA, CPRD and NIBSC.

Read our guidance on coronavirus (COVID19)
https://www.gov.uk/government/collections/mhra-guidance-on-coronavirus-covid-19



Brett Sutton's EA:

Dear J>>>>,

Thank you for your email to the Chief Health Officer,

Your message of support and your advice below has been provided to Professor Sutton and his team.

Kind Regards,

L>>>>| EA to the Chief Health Officer
Office of the Chief Health Officer
COVID-19 Response Division | Department of Health
E: [email protected]

1. www.health.vic.gov.au